Post hoc analysis of responses to ponatinib in patients with chronic-phase chronic myeloid leukemia (CPCML) by baseline BCR::ABL1 level and baseline mutation status in the OPTIC trial Meeting Abstract
| Authors: | Deininger, M.; Apperley, J.; Arthur, C. K.; Chuah, C.; Hochhaus, A.; de Lavallade, H.; Lipton, J.; Lomaia, E.; McCloskey, J.; Maness, L.; Mauro, M.; Moraghi, B.; Pavlovsky, C.; Rosti, G.; Rousselot, P.; Sutton, M. U.; Ren, X.; Vorog, A.; Cortes, J. |
| Abstract Title: | Post hoc analysis of responses to ponatinib in patients with chronic-phase chronic myeloid leukemia (CPCML) by baseline BCR::ABL1 level and baseline mutation status in the OPTIC trial |
| Meeting Title: | 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | leukemia; cml; tki; ponatinib; t315i |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Sep 28-Oct 1 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S285 |
| End Page: | S286 |
| Language: | English |
| ACCESSION: | WOS:000897948100238 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(22)01359-3 |
| Notes: | Meeting Abstract: CML-047 -- Source: Wos |
